Bristol Myers Squibb Investor

Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Technology: Biotechnology, Cell_Therapies, Health Care, Medical, Pharmaceutical
Industry: AI, End-to-end Drug Development
Headquarters: New York, New York, United States
Founded Date: 1887-01-01
Employees Number: 10001+
Funding Status: IPO
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Venture
Number Of Exits: 10
Acquisitions Number: Made Acquisitions
Investors Number: 13
Total Funding: 80000000
Estimated Revenue: $1B to $10B
Last Funding Date: 2022-02-15
Last Funding Type: Post-IPO Debt

Visit Website
Register and Claim Ownership